International Journal of Dermatology

Cover image for International Journal of Dermatology

January 2003

Volume 42, Issue 1

Pages 26–81

  1. Correspondence

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with atypical cells (pages 26–28)

      R. Rivera, P. Ortiz, J.-L. Rodriguez-Peralto, F. Vanaclocha and L. Iglesias

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.16981.x

  2. Board of Directors List

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
  3. Basic science review

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
  4. Reports

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Kaposi's sarcoma in renal transplant patients: experience at the Cruces Hospital in Bilbao (pages 18–22)

      Josune Mitxelena, Pablo Gomez-Ullate, Antonio Aguirre, Gurutze Rubio, Ildefonso Lampreabe and José Luis Díaz-Pérez

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01636.x

    2. Antimicrobial resistance of Staphylococcus aureus isolated from impetigo patients between 1994 and 2000 (pages 23–25)

      Setsuko Nishijim, 1 Shigeo Ohshima, 1 Toshiaki Higashida, 1 Hideo Nakaya and 2 Ichiro Kurokawa 3

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01616.x

  5. Mehregan Supplement Introduction and commentary

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Amir Mehregan as I remember him (pages 29–30)

      A. Bernard Ackerman

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01651.x

  6. Mehregan Supplement Review

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Scleromyxedema revisited (pages 31–35)

      John J. Pomann and Earl J. Rudner

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01565.x

  7. Mehregan Supplement Report

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Large cell acanthoma (pages 36–39)

      Darius R. Mehregan, Fasahat Hamzavi and Karl Brown

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01587.x

  8. Mehregan Supplement Basic science review

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
  9. Mehregan Supplement Commentary

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Felix Pinkus: dermatologist, dermatopathologist, and artist (page 44)

      David A. Mehregan

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01564.x

  10. Mehregan Supplement Report

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Assessment of histologic criteria in the diagnosis of mycosis fungoides (pages 45–52)

      Zahra Safee Naraghi, Hassan Seirafi, Mahin Valikhani, Forshad Farnaghi, Susan Kavusi and Yahya Dowlati

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01566.x

  11. Mehregan Supplement Pharmacology and therapeutics

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
  12. Mehregan Supplement Reports

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Value of histopathology in vitiligo (pages 57–61)

      Leopold F. Montes, Jorge Abulafia, Walter H. Wilborn, Barbara M. Hyde and Carolina M. Montes

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01743.x

    2. Wells’ syndrome: a clinical and histopathologic review of seven cases (pages 62–67)

      Meena Moossavi and Darius R. Mehregan

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01705.x

  13. Mehregan Supplement Cameos

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. Apocrine carcinoma of the vulva in a band-like arrangement with inflammatory and telangiectatic metastasis via local lymphatic channels (pages 71–74)

      Takahiro Kiyohara, Masanobu Kumakiri, Kenya Kawami, Sachio Kouraba, Akiteru Takeuchi, Takahiro Sawai, Lin-Min Lao, Shinichi Ansai and Ken Hashimoto

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01568.x

    2. Familial anetoderma (pages 75–77)

      Jean E. Thomas, Darius R. Mehregan, Jean Holland and David A. Mehregan

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01742.x

  14. Mehregan Supplement Editorial

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings
    1. A call to action for early melanoma detection (pages 78–80)

      J. B. Howell

      Version of Record online: 4 FEB 2003 | DOI: 10.1046/j.1365-4362.2003.01574.x

  15. Forthcoming society meetings

    1. Top of page
    2. Correspondence
    3. Board of Directors List
    4. Basic science review
    5. Reports
    6. Mehregan Supplement Introduction and commentary
    7. Mehregan Supplement Review
    8. Mehregan Supplement Report
    9. Mehregan Supplement Basic science review
    10. Mehregan Supplement Commentary
    11. Mehregan Supplement Report
    12. Mehregan Supplement Pharmacology and therapeutics
    13. Mehregan Supplement Reports
    14. Mehregan Supplement Cameos
    15. Mehregan Supplement Editorial
    16. Forthcoming society meetings

SEARCH

SEARCH BY CITATION